piR-823 inhibits cell apoptosis via modulating mitophagy by binding to PINK1 in colorectal cancer

Shuling Wang1, Xiaoyu Jiang1, Xiaoli Xie1

  • 1Department of Gastroenterology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, Hebei Clinical Research Center for Digestive Diseases, Shijiazhuang, Hebei, China.

Insights

This study reveals piR-823 promotes colorectal cancer by inhibiting mitophagy. piR-823 targets PINK1 for degradation, disrupting mitochondrial quality control and promoting tumor growth.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Mitophagy is crucial for mitochondrial homeostasis and is implicated in cancer.
  • Noncoding RNA piR-823 is linked to colorectal cancer development.

Purpose of the Study:

  • To investigate the role of piR-823 in regulating mitophagy within colorectal cancer (CRC).
  • To elucidate the molecular mechanisms by which piR-823 influences mitophagy and CRC progression.

Main Methods:

  • Digital gene expression analysis, antagomir/mimic treatments, in vivo/in vitro mitophagy assays (immunofluorescence, western blot).
  • Mitochondrial function assessment (JC-1 staining, ATP production), gene silencing (siRNA), molecular interaction studies (RNA pull-down, RIP).

Main Results:

  • Inhibition of piR-823 (Ant-823) enhanced mitophagy and Parkin activation, leading to mitochondrial dysfunction in CRC cells.
  • Increased piR-823 (mimics-823) suppressed mitophagy.
  • piR-823 directly interacts with PINK1, promoting its ubiquitination and proteasomal degradation, thereby inhibiting mitophagy.
  • Parkin inhibition attenuated the effects of Ant-823 on mitochondrial loss and apoptosis.

Conclusions:

  • piR-823 acts as a novel regulator of mitophagy in colorectal cancer.
  • The mechanism involves piR-823-mediated degradation of PINK1, impairing mitophagy and promoting CRC tumorigenesis.
  • Findings were validated in patient-derived colorectal cancer samples.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.2K